A prosecution witness in the alleged N2.26 billion fraud trial involving former Minister of Labour and Employment, Chris Ngige, has told the court that he received presidential directives to implement decisions arising from an investigative panel set up to examine the activities of the Nigeria Social Insurance Trust Fund (NSITF).
The witness, Onwusoro Maduka Iheamelam, a Permanent Secretary in the Federal Ministry of Special Duties and Intergovernmental Affairs, gave the testimony on Thursday, November 12, 2026, during the resumed hearing before Justice M.A. Hassan of the Federal Capital Territory High Court, Abuja.
Iheamelam, the third prosecution witness called by the Economic and Financial Crimes Commission (EFCC), disclosed during cross-examination by defence counsel, P.I.N. Ikwueto, SAN, that he was a member of the presidential investigative panel established to probe the activities of the NSITF during Ngige’s tenure as minister.
He told the court that he received a presidential directive to implement decisions taken by the president following the panel’s findings, including those relating to the procurement functions and other activities of the fund.
The proceedings also featured a disagreement between the prosecution and defence over access to the witness’s statements.
Defence counsel, Ikwueto, requested that the prosecution produce the original copies of the witness’s statements for examination.
However, EFCC counsel, Sylvanus Tahir, SAN, objected, arguing that the defence should formally apply for Certified True Copies (CTCs) of the documents if it wished to obtain them.
Ngige is facing an eight-count charge bordering on alleged abuse of office and fraudulent contract awards involving NSITF contracts valued at N2,261,722,535.84.
The charges relate to alleged irregularities in the award of contracts during his tenure as Minister of Labour and Employment and his supervision of the NSITF.
Following Thursday’s proceedings, Justice Hassan adjourned the case until February 9, 10 and 11, 2027, for continuation of trial.
We do everything possible to supply quality news and information to all our valuable readers day in, day out and we are committed to keep doing this.
Your kind donation will help our continuous research efforts.




















